Also available in Persian — نسخه فارسی EN فا
❓ Unknown

Ten Thousand COVID-19 Deaths Worldwide in One Month

Feb 5, 2026 February 5, 2026 3 min read 📰 VOA Persian
📋 Key Takeaway

The World Health Organization reported nearly 10,000 COVID-19 deaths worldwide in December, with significant increases in hospitalizations and ICU admissions. The new 'GN.1' variant is spreading, raising concerns about its potential entry into Iran, where health authorities have not yet identified it despite its high transmissibility.

🔍 Quick Context Guide
💡 Bottom Line: The emergence of the 'GN.1' variant and rising COVID-19 deaths signal ongoing public health challenges that could significantly impact Iran and beyond.

👥 Key Players

Tedros Adhanom MENTIONED
Secretary-General of the World Health Organization
"He leads the global health response to pandemics and is a key figure in managing COVID-19 information and strategies."
Bahram Einollahi MENTIONED
Minister of Health of Iran
"He oversees Iran's health policies and responses to COVID-19, impacting public health measures and vaccination strategies."

📰 What Happened

The World Health Organization reported nearly 10,000 COVID-19 deaths in December, with a significant rise in hospitalizations and ICU admissions due to the new 'GN.1' variant. Concerns are growing about the variant's potential spread to Iran, where health authorities have not yet detected it.

  • 42% increase in hospitalizations and 62% increase in ICU admissions compared to November.
  • The 'GN.1' variant is highly transmissible and may evade immunity.

💡 Why It Matters

🇮🇷 For Iran: The rise of the 'GN.1' variant poses a risk to public health in Iran, especially given the country's delayed identification of new variants and limited vaccine options.
🌍 Regional: Increased COVID-19 cases in Iran could affect neighboring countries, especially if borders remain open.
🌐 International: The global response to COVID-19 may be impacted by the emergence of new variants, influencing international travel and health policies.

📚 Background

COVID-19 continues to evolve, with new variants emerging that may spread more easily and evade immunity, complicating global health responses.

COVID-19 variants Vaccination strategies
📡 Source: INTERNATIONAL
📊 Confidence: 70%
The information comes from the World Health Organization, which is generally considered a reliable source for global health data.

Tedros Adhanom, the Secretary-General of the World Health Organization, stated that nearly 10,000 deaths due to COVID-19 were reported in December of last year, adding that hospital admissions and intensive care unit (ICU) admissions have increased due to gatherings and holiday travel. He mentioned in a press conference in Geneva, 'Although COVID-19 is no longer a global health emergency, the virus continues to circulate, mutate, and take lives.' The World Health Organization reported a 42% increase in hospitalizations and a 62% increase in ICU admissions compared to November of last year, based on data from about 50 countries, mostly in Europe and the Americas. Mr. Adhanom emphasized that this is only a glimpse of reality, noting that several countries have stopped reporting COVID-19 statistics to the organization, which he deemed a major problem. Currently, the variant known as 'GN.1,' a sub-lineage of Omicron, is circulating. The U.S. Centers for Disease Control and Prevention predicts that cases of the new variant will increase over the winter. This U.S. health agency states there is no evidence that the new variant causes more severe illness, but its rapid spread suggests it may be more transmissible or better at evading the immune system than other coronavirus variants. The 'GN.1' variant appeared in the U.S. in September of last year and is closely related to 'BA.2.86' (Pirola), which is considered a sub-lineage of Omicron. In Iran, new COVID-19 variants are typically identified with a delay of two to three months compared to other countries. This is concerning as the new variant is highly contagious, and experts believe that due to open borders and reduced adherence to health protocols, the likelihood of this variant entering Iran is high. However, a health ministry official stated last week that the new variant has not been identified. The technical deputy of the Ministry of Health's Center for Communicable Disease Management mentioned that about 30% of respiratory illness cases are related to influenza, 10% to COVID-19, and the rest to other respiratory viruses. Simultaneously, Bahram Einollahi, the Minister of Health, stated, 'Those who have cold symptoms either have COVID-19 or influenza.' Although numerous studies in various countries have shown that multi-valent mRNA vaccines are more effective in preventing severe illness than other types of vaccines and are less affected by waning immunity over time, the Islamic Republic has refrained from importing these types of vaccines. The increase in respiratory illnesses in China, Iran, and other countries; Dr. Attari: We are not facing a new virus. The scientific committee for combating COVID-19 in Iran has repeatedly called for the inclusion of Pfizer's pill in the country's medication list. A Voice of America investigative report; scientific assessment of the published research on the performance of the Barakat vaccine. Identification of a highly mutated coronavirus variant; Mahan Ghafari: We may enter a new wave. Research results on vaccination in Iran; tens of thousands could have survived.

🌐

Translated from the original and edited for English readers. View original source →

Translation confidence: 85%

📰 Related Coverage

⚖️ Independent Platform — Artesh.com is not affiliated with any government, military, or political organization. Editorial Policy →